Assenagon Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,873
| Closed | -$81.9K | – | 1459 |
|
|
2024
Q2 | $81.9K | Sell |
15,873
-154,126
| -91% | -$795K | ﹤0.01% | 1353 |
|
|
2024
Q1 | $909K | Buy |
169,999
+144,869
| +576% | +$775K | ﹤0.01% | 1057 |
|
|
2023
Q4 | $196K | Hold |
25,130
| – | – | ﹤0.01% | 1323 |
|
|
2023
Q3 | $99.3K | Buy |
25,130
+14,754
| +142% | +$58.3K | ﹤0.01% | 1311 |
|
|
2023
Q2 | $32.7K | Hold |
10,376
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q1 | $27.7K | Buy |
+10,376
| New | +$27.7K | ﹤0.01% | 1352 |
|
|
2021
Q4 | – | Sell |
-8,707
| Closed | -$389K | – | 1538 |
|
|
2021
Q3 | $389K | Sell |
8,707
-2,872
| -25% | -$128K | ﹤0.01% | 1058 |
|
|
2021
Q2 | $631K | Buy |
+11,579
| New | +$631K | ﹤0.01% | 958 |
|
|
2019
Q2 | – | Sell |
-3,450
| Closed | -$315K | – | 1160 |
|
|
2019
Q1 | $315K | Sell |
3,450
-5,570
| -62% | -$509K | ﹤0.01% | 820 |
|
|
2018
Q4 | $502K | Buy |
+9,020
| New | +$502K | 0.01% | 774 |
|